دورية أكاديمية

4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.

التفاصيل البيبلوغرافية
العنوان: 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.
المؤلفون: Ma, Tianjiao1 (AUTHOR), Zheng, Zongyu1 (AUTHOR), Guo, Hua1 (AUTHOR), Lian, Xin1 (AUTHOR), Rane, Madhavi J.1 (AUTHOR), Cai, Lu1 (AUTHOR), Kim, Ki Soo1 (AUTHOR), Kim, Kyoung Tae1 (AUTHOR), Zhang, Zhiguo1 (AUTHOR) zg529@163.com, Bi, Liqi1 (AUTHOR) biliqi66@126.com
المصدر: Toxicology & Applied Pharmacology. May2019, Vol. 370, p93-105. 13p.
مصطلحات موضوعية: *FATTY acid oxidation, *OXIDATIVE stress, *HIGH-fat diet, *TYPE 2 diabetes, *MICE, *DIABETIC nephropathies
مستخلص: Abstract Diabetic nephropathy (DN) is one of the most serious long-term complications of type 2 diabetes (T2D). 4- O -methylhonokiol (MH) is one of the biologically active ingredients extracted from the Magnolia stem bark. In this study, we aim to elucidate whether treatment with MH can ameliorate or slow-down progression of DN in a T2D murine model and, if so, whether the protective response of MH correlates with AMPK-associated anti-oxidant and anti-inflammatory effects. To induce T2D, mice were fed normal diet (ND) or high fat diet (HFD) for 3 months to induce insulin resistance, followed by an intraperitoneal injection of STZ to induce hyperglycemia. Both T2D and control mice received gavage containing vehicle or MH once diabetes onset for 3 months. Once completing 3-month MH treatment, five mice from each group were sacrificed as 3 month time-point. The rest mice in each group were sacrificed 3 months later as 6 month time-point. In T2D mice, the typical DN symptoms were induced as expected, reflected by increased proteinuria, renal lipid accumulation and lipotoxic effects inducing oxidative stress, and inflammatory reactions, and final fibrosis. However, these typical DN changes were significantly prevented by MH treatment for 3 months and even at 3 months post-MH withdrawal. Mechanistically, MH renal-protection from DN may be related to lipid metabolic improvement and oxidative stress attenuation along with increases in AMPK/PGC-1α/CPT1B-mediated fatty acid oxidation and Nrf2/SOD2-mediated anti-oxidative stress. Results showed the preventive effect of MH on the renal oxidative stress and inflammation in DN. Highlights • 4- O -methylhonokiol (MH) prevented T2D-induced renal injury. • MH increased AMPK/PGC-1α/CPT1B-mediated fatty acid oxidation. • MH actived Nrf2-mediated anti-oxidative stress. • MH treatment was still protective after 3 months of MH withdrawal in DN mice [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:0041008X
DOI:10.1016/j.taap.2019.03.007